Literature DB >> 30604194

B Cells Increase Myocardial Inflammation by Suppressing M2 Macrophage Polarization in Coxsackie Virus B3-Induced Acute Myocarditis.

Yong Li1, Yanlan Huang1, Weifeng Wu2, Bin Wei1, Lin Qin1.   

Abstract

The role of B cells in viral myocarditis (VMC) remains controversial. In order to establish a role and mechanism of action for B cells in acute VMC, we established an acute VMC mouse model by intraperitoneal injection of Coxsackie virus group B type 3 (CVB3). At day 7, mice were analyzed using myocardial histopathology, and the presence of M2 macrophages in spleen and heart. Mice were divided into four groups, all having a C57BL/6 background: control group; wild-type (WT) VMC; mMt/mMt (-/-) VMC (BKO), and BKO + B cell VMC. A role for B cells was demonstrated by a significant reduction in myocardial pathological score and an increase in the frequency of M2 macrophages in the BKO group, when compared to the WT group. Once BKO mice underwent B cell reconstitution with isolated WT B cells, the myocardial pathological score was increased significantly, while the frequency of M2 macrophages decrease. Our findings demonstrate that B cells increase myocardial inflammation by suppressing M2 polarization in acute VMC in vivo.

Entities:  

Keywords:  B cells; macrophage; polarization; viral myocarditis

Year:  2019        PMID: 30604194     DOI: 10.1007/s10753-018-0950-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  31 in total

Review 1.  Macrophage activation and polarization as an adaptive component of innate immunity.

Authors:  Massimo Locati; Alberto Mantovani; Antonio Sica
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

2.  Gene therapy with CCL2 (MCP-1) mutant protects CVB3-induced myocarditis by compromising Th1 polarization.

Authors:  Yan Yue; Jun Gui; Wei Xu; Sidong Xiong
Journal:  Mol Immunol       Date:  2010-12-17       Impact factor: 4.407

3.  B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses.

Authors:  Sara J Ireland; Alyssa A Guzman; Elliot M Frohman; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2015-11-26       Impact factor: 3.478

Review 4.  Effector and regulatory B cells: modulators of CD4+ T cell immunity.

Authors:  Frances E Lund; Troy D Randall
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

5.  Increased Mobilization of CD45+CD34+VLA-4+ Cells in Acute Viral Myocarditis Induced by Coxsackievirus B3.

Authors:  Xingcui Gao; Bin Wei; Yan Deng; Yan Lan Huang; Weifeng Wu
Journal:  Cardiology       Date:  2017-09-02       Impact factor: 1.869

6.  Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.

Authors:  Kang Li; Wei Xu; Qiang Guo; Zhenggang Jiang; Ping Wang; Yan Yue; Sidong Xiong
Journal:  Circ Res       Date:  2009-07-16       Impact factor: 17.367

7.  The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.

Authors:  G Cambridge; H C Perry; L Nogueira; G Serre; H M Parsons; I De La Torre; M C Dickson; M J Leandro; J C W Edwards
Journal:  J Autoimmun       Date:  2013-12-22       Impact factor: 7.094

8.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors:  Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

9.  Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.

Authors:  Urs Eriksson; Romeo Ricci; Lukas Hunziker; Michael O Kurrer; Gavin Y Oudit; Tania H Watts; Ivo Sonderegger; Kurt Bachmaier; Manfred Kopf; Josef M Penninger
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

10.  Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis.

Authors:  Qing Kong; Weifeng Wu; Fan Yang; Yanli Liu; Yimin Xue; Mengsha Gao; Wenyin Lai; Xiaofen Pan; Yuluan Yan; Yu Pang; Yuanhua Deng
Journal:  Virol J       Date:  2012-10-11       Impact factor: 4.099

View more
  8 in total

1.  The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis.

Authors:  Jing Lu; Zhihong Cen; Quan Tang; Jingwei Dong; Lin Qin; Weifeng Wu
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

Review 2.  The Role of B Cells in Cardiomyopathy and Heart Failure.

Authors:  Kevin Bermea; Aashik Bhalodia; Angelo Huff; Sylvie Rousseau; Luigi Adamo
Journal:  Curr Cardiol Rep       Date:  2022-06-11       Impact factor: 3.955

3.  The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis.

Authors:  Jing Lu; Zhihong Cen; Quan Tang; Jingwei Dong; Lin Qin; Weifeng Wu
Journal:  Clin Exp Immunol       Date:  2022-02-08       Impact factor: 5.732

4.  Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling.

Authors:  Wenzheng Xia; Changlin Zou; Hanbin Chen; Congying Xie; Meng Hou
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

5.  lncRNA AK085865 Promotes Macrophage M2 Polarization in CVB3-Induced VM by Regulating ILF2-ILF3 Complex-Mediated miRNA-192 Biogenesis.

Authors:  Yingying Zhang; Xueqin Li; Chen Wang; Mengying Zhang; Hui Yang; Kun Lv
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-25       Impact factor: 8.886

6.  Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Frank Spillmann; Maximilian G Posch; Petra Reinke; Hans-Dieter Volk; Ahmed Elsanhoury; Uwe Kühl
Journal:  Eur Heart J Case Rep       Date:  2019-09-01

Review 7.  Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases.

Authors:  Jana Zarubova; Xuexiang Zhang; Tyler Hoffman; Mohammad Mahdi Hasani-Sadrabadi; Song Li
Journal:  Matter       Date:  2021-03-09

Review 8.  Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure.

Authors:  Colton R Martens; Federica Accornero
Journal:  Viruses       Date:  2021-09-24       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.